Community pharmacies incentivised to refer frequent users of reliever inhalers to general practice The new referral incentive will be part of the Pharmacy Quality Scheme for 2022/2023.…
NHS Scotland announces plan to switch patients to greener inhalers A strategy document, published by NHS Scotland, says that improvements in the way asthma and chronic obstructive pulmonary disease are managed could help reduce metered dose inhaler use.…
Best practice principles for inhaler prescribing How to select appropriate inhaler devices that balance the need to personalise treatment and optimise disease control while reducing the environmental impact of prescribing.…
More than a quarter of patients overusing rescue inhalers for asthma, study finds Researchers from Queen Mary University London warned that salbutamol inhalers can increase risk of anxiety and tachycardia.…
Metered-dose inhaler classed as ‘carbon neutral’ through offsetting Lupin Healthcare, which manufactures the Luforbec inhaler, offsets the total emissions produced from production, use and disposal of the inhaler, making it carbon neutral.…
How switching a handful of patients’ inhalers saved nearly 5,000kgCO2e While switching inhalers may not be for everyone, reviewing patients who may benefit from a lower carbon device could have an enormous impact.…
Some patients switched to ‘greener’ inhalers without consultation, say experts Exclusive: Experts warn that non-consented inhaler switches pose risks to patients' health and advise physicians to carry out individual inhaler checks to avoid this.…
Switches to dry powder inhalers could halve carbon footprint, study results suggest Patients switched to a dry powder inhaler produced 132kg less annual carbon dioxide equivalent than those using metred-dose inhalers, and had better asthma control.…
Minister urged to block takeover of inhaler manufacturer by tobacco firm The Royal Pharmaceutical Society has written to the government to express its concerns around the proposed takeover of inhaler manufacturer Vectura by tobacco company Philip Morris International.…
Reducing asthma medication does not worsen outcomes but could save money, study suggests Stepping down asthma medication does not adversely affect patient outcomes and could save millions of pounds in medicines costs, a study in PLoS Medicine has found.…
